OncoMark, a University College Dublin (UCD) spin-out company, today announced that is has secured €2.1 million in funding. The funding round included; Kernel Capital, through the Bank of Ireland Kernel Capital Venture Funds, the Irrus Investments syndicate, the Galway HBAN MedTech syndicate, private investors and Enterprise Ireland. OncoMark is focused on the development of novel [...]
OncoMark is an Ireland-based molecular diagnostics company that develops and commercializes cancer biomarkers for the detection and treatment of breast cancer.